Caricamento...
Asenapine versus placebo for schizophrenia
BACKGROUND: Schizophrenia is a highly prevalent and chronic disorder that comprises a wide range of symptomatology. Asenapine is a recently developed atypical antipsychotic that is approved by the US Food and Drug Administration (FDA) for the treatment of schizophrenia. OBJECTIVES: To determine the...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2015
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464872/ https://ncbi.nlm.nih.gov/pubmed/26599405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011458.pub2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|